View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Moody's assigns Baa2 rating to Smith & Nephew's new USD notes

Moody's Ratings (Moody's) has today assigned Baa2 senior unsecured ratings to UK-based medical products and devices manufacturer Smith & Nephew plc's (Smith & Nephew or the company) new USD notes issue. The notes will have a split maturity, of three and ten years. The existing long-term issuer ratin...

Smith & Nephew plc: Update to credit analysis

Our credit view of this issuer reflects its weak cash flow metrics offset by its financial policy and good product and geographic diversification.

Smith & Nephew plc: Sales guidance raised but margins hurt by cost inf...

Despite Smith & Nephew reporting sales growth in the first half of 2023, profitability and cash flow were under pressure.

Moody's assigns Baa2 rating to Smith & Nephew's proposed Euro notes

Moody's Investors Service ("Moody's") has assigned a Baa2 senior unsecured rating to Smith & Nephew plc's (S&N, Smith & Nephew or the company) proposed €500 million notes. The offering marks Smith & Nephew plc's debut in the public Eurobond market. Proceeds from the new proposed notes will be used f...

Smith & Nephew plc: Slower recovery in credit metrics offset by resili...

Our credit view of this issuer reflecting temporary pressures on EBITDA and cash flow generation but solid long-term demand and relatively conservative financial policy.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Moody's announces completion of a periodic review of ratings of Smith ...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Smith& Nephew plc. Global Credit Research- 08 Dec 2021. London, 08 December 2021-- Moody's Investors Service has completed a periodic review of the ratings of Smith& Nephew plc and other ratings that are associated with the same analytical unit.

Smith & Nephew PLC: Good recovery from coronavirus but return to pre-p...

Our credit view of S&N reflecting its good degree of diversification and moderate leverage, offset by a delayed EBITDA recovery from coronavirus and a step down in otherwise solid cash flows

Moody's announces completion of a periodic review of ratings of Smith ...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Smith& Nephew plc. Global Credit Research- 15 Jan 2021. London, 15 January 2021-- Moody's Investors Service has completed a periodic review of the ratings of Smith& Nephew plc and other ratings that are associated with the same analytical unit.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Smith & Nephew plc: New Issuer

Our credit view of Smith & Nephew, reflecting its good degree of product and geographic diversification, offset by planned step-up in leverage.

Moody's assigns Baa2 senior unsecured rating to Smith & Nephew's notes...

Rating Action: Moody's assigns Baa2 senior unsecured rating to Smith& Nephew's notes offering. Global Credit Research- 07 Oct 2020. London, 07 October 2020-- Moody's Investors Service has assigned a first time Baa2 senior unsecured rating to Smith& Nephew plc's proposed new notes, to be issued in the aggregate amount of $1 billion.

Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stab...

Rating Action: Moody's assigns Baa2 issuer rating to Smith& Nephew plc; outlook stable. Global Credit Research- 05 Oct 2020. London, 05 October 2020-- Moody's Investors Service has assigned a Baa2 first time long-term issuer rating to UK-based medical products and devices manufacturer Smith& Nephew plc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

BAC BANK OF AMERICA CORP
ANTM ANTHEM INC.
ILMN ILLUMINA INC.
CVA COVANTA HOLDING CORPORATION
DEI DOUGLAS EMMETT INC
BK BANK OF NEW YORK MELLON CORPORATION
C CITIGROUP INC.
WIRE ENCORE WIRE CORPORATION
TS TENARIS S.A. ADS
TPRE SIRIUSPOINT LTD
TFX TELEFLEX INCORPORATED
SU. SUNCOR ENERGY INC.
SJI SOUTH JERSEY INDUSTRIES INC.
SIGI SELECTIVE INSURANCE GROUP INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
SCHL SCHOLASTIC CORPORATION
SBNY SIGNATURE BANK
RNST RENASANT CORPORATION
PSB PS BUSINESS PARKS INC.
PPC PILGRIM'S PRIDE CORPORATION
OFC CORPORATE OFFICE PROPERTIES TRUST
NWE NORTHWESTERN CORPORATION
NTCT NETSCOUT SYSTEMS INC.
MO ALTRIA GROUP INC
MEI METHODE ELECTRONICS INC.
LGND LIGAND PHARMACEUTICALS INCORPORATED
JWN NORDSTROM INC.
IPAR INTER PARFUMS INC.
INDB INDEPENDENT BANK CORP.
IDA IDACORP INC.
PU6D HSBC HOLDINGS (ADR)
HMSY HMS HOLDINGS CORP.
HIG HARTFORD FINANCIAL SERVICES GROUP INC.
GNTX GENTEX CORPORATION
GLN GLATFELTER CORPORATION
FRT FEDERAL REALTY INVESTMENT TRUST
FRME FIRST MERCHANTS CORPORATION
EOG EOG RESOURCES INC.
ENTA ENANTA PHARMACEUTICALS INC.
EGBN EAGLE BANCORP INC.
CVBF CVB FINANCIAL CORP.
CRS CARPENTER TECHNOLOGY CORPORATION
CR CRANE CO.
COHR COHERENT INC.
CATY CATHAY GENERAL BANCORP
BP BP PLC ADS
KRNY KEARNY FINANCIAL CORP.
UVE UNIVERSAL INSURANCE HOLDINGS INC.
NPWA SMITH & NEPHEW PLC
BRC BRADY CORPORATION CLASS A
DRQ DRIL-QUIP INC.
KALU KAISER ALUMINUM CORPORATION
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
THG HANOVER INSURANCE GROUP INC.
HNW PIONEER DIVERSIFIED HIGH INCOME TRUST
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
TR TOOTSIE ROLL INDUSTRIES INC.
STBA S&T BANCORP INC.
HOPE HOPE BANCORP INC.
ATGE ADTALEM GLOBAL EDUCATION INC.
BXS BANCORPSOUTH BANK
BKNG BOOKING HOLDINGS INC.
CI CIGNA CORPORATION
TCF TCF FINANCIAL CORPORATION
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Debbie Wang
  • Debbie Wang

Morningstar | Smith & Nephew Climbs the Value Chain Under New Manageme...

While we continue to think Smith & Nephew faces key challenges in remaining an independent, mid-sized company in a medical technology world that has come to reward consolidation and scale, we like the steps new CEO Namal Nawana has taken to broaden the firm’s product portfolio into adjacent and complimentary markets. These additions do not necessarily widen Smith & Nephew’s narrow economic moat, but they help to reinforce the firm’s competitive position in advanced wound care, in our opini...

Debbie Wang
  • Debbie Wang

Smith & Nephew Climbs the Value Chain Under New Management

While we continue to think Smith & Nephew faces key challenges in remaining an independent, mid-sized company in a medical technology world that has come to reward consolidation and scale, we like the steps new CEO Namal Nawana has taken to broaden the firm’s product portfolio into adjacent and complimentary markets. These additions do not necessarily widen Smith & Nephew’s narrow economic moat, but they help to reinforce the firm’s competitive position in advanced wound care, in our opi.....

Debbie Wang
  • Debbie Wang

Morningstar | Smith & Nephew Ventures into Regenerative Medicine with ...

Smith & Nephew's impressive innovation has allowed the company to carve out a slice of the orthopedic and wound-care markets. Though Smith & Nephew is smaller than the dominant orthopedic competitors, it has been a strong contributor in terms of introducing meaningful innovation with its pioneering hip resurfacing implant and knee replacements with Verilast technology, which the firm contends can last for 30 years. These are significant improvements that exceed the evolutionary innovation typica...

Debbie Wang
  • Debbie Wang

Smith & Nephew Ventures into Regenerative Medicine with Latest Acquisi...

Smith & Nephew finished up 2018 not materially far off from our projections and we’re leaving our fair value unchanged for now. Similar to previous quarters, large joint implants continued to lag market growth in the fourth quarter. Accounting for roughly one third of total revenue, quarterly knees and hips rose 3% on an underlying basis, which was then whittled down to 1% by foreign exchange headwinds. The main bright spots came in the form of sports medicine, the Navio hand-held orthopedic.....

Debbie Wang
  • Debbie Wang

Morningstar | Smith & Nephew Prepares for More M&A Activity

Smith & Nephew finished up 2018 not materially far off from our projections and we’re leaving our fair value unchanged for now. Similar to previous quarters, large joint implants continued to lag market growth in the fourth quarter. Accounting for roughly one third of total revenue, quarterly knees and hips rose 3% on an underlying basis, which was then whittled down to 1% by foreign exchange headwinds. The main bright spots came in the form of sports medicine, the Navio hand-held orthopedic r...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch